Entereg (alvimopan)
Entereg (alvimopan) market is segmented by region (country), players, by Type and by Application. ... Read More
Global and United States Lacosamide Market Report & Forecast 2023-2028
1 Study Coverage
1.1 Lacosamide Revenue in Lacosamide Business (2017-2022) & (US$ Million) Introduction
1.2 Global Lacosamide Outlook 2017 VS 2022 VS 2028
1.2.1 Global Lacosamide Market Size for the Year 2017-2028
1.2.2 Global Lacosamide Market Size for the Year 2017-2028
1.3 Lacosamide Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Lacosamide in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Lacosamide Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Lacosamide Market Dynamics
1.4.1 Lacosamide Industry Trends
1.4.2 Lacosamide Market Drivers
1.4.3 Lacosamide Market Challenges
1.4.4 Lacosamide Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Lacosamide by Type
2.1 Lacosamide Market Segment by Type
2.1.1 Oral tablets
2.1.2 Oral solution
2.1.3 Intravenous
2.2 Global Lacosamide Market Size by Type (2017, 2022 & 2028)
2.3 Global Lacosamide Market Size by Type (2017-2028)
2.4 United States Lacosamide Market Size by Type (2017, 2022 & 2028)
2.5 United States Lacosamide Market Size by Type (2017-2028)
3 Lacosamide by Application
3.1 Lacosamide Market Segment by Application
3.1.1 Adults
3.1.2 Pediatric patients
3.2 Global Lacosamide Market Size by Application (2017, 2022 & 2028)
3.3 Global Lacosamide Market Size by Application (2017-2028)
3.4 United States Lacosamide Market Size by Application (2017, 2022 & 2028)
3.5 United States Lacosamide Market Size by Application (2017-2028)
4 Global Lacosamide Competitor Landscape by Company
4.1 Global Lacosamide Market Size by Company
4.1.1 Top Global Lacosamide Companies Ranked by Revenue (2021)
4.1.2 Global Lacosamide Revenue by Player (2017-2022)
4.2 Global Lacosamide Concentration Ratio (CR)
4.2.1 Lacosamide Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Lacosamide in 2021
4.2.3 Global Lacosamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Lacosamide Headquarters, Revenue in Lacosamide Business (2017-2022) & (US$ Million) Type
4.3.1 Global Lacosamide Headquarters and Area Served
4.3.2 Global Lacosamide Companies Revenue in Lacosamide Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Lacosamide Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Lacosamide Market Size by Company
4.5.1 Top Lacosamide Players in United States, Ranked by Revenue (2021)
4.5.2 United States Lacosamide Revenue by Players (2020, 2021 & 2022)
5 Global Lacosamide Market Size by Region
5.1 Global Lacosamide Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Lacosamide Market Size by Region (2017-2028)
5.2.1 Global Lacosamide Market Size by Region: 2017-2022
5.2.2 Global Lacosamide Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Lacosamide Market Size YoY Growth 2017-2028
6.1.2 North America Lacosamide Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Lacosamide Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Lacosamide Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Lacosamide Market Size YoY Growth 2017-2028
6.3.2 Europe Lacosamide Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Lacosamide Market Size YoY Growth 2017-2028
6.4.2 Latin America Lacosamide Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Lacosamide Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Lacosamide Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 UCB
7.1.1 UCB Company Details
7.1.2 UCB Business Overview
7.1.3 UCB Lacosamide Introduction
7.1.4 UCB Revenue in Lacosamide Business (2017-2022)
7.1.5 UCB Recent Development
7.2 Teva
7.2.1 Teva Company Details
7.2.2 Teva Business Overview
7.2.3 Teva Lacosamide Introduction
7.2.4 Teva Revenue in Lacosamide Business (2017-2022)
7.2.5 Teva Recent Development
7.3 Amneal Pharmaceuticals
7.3.1 Amneal Pharmaceuticals Company Details
7.3.2 Amneal Pharmaceuticals Business Overview
7.3.3 Amneal Pharmaceuticals Lacosamide Introduction
7.3.4 Amneal Pharmaceuticals Revenue in Lacosamide Business (2017-2022)
7.3.5 Amneal Pharmaceuticals Recent Development
7.4 MSN Laboratories
7.4.1 MSN Laboratories Company Details
7.4.2 MSN Laboratories Business Overview
7.4.3 MSN Laboratories Lacosamide Introduction
7.4.4 MSN Laboratories Revenue in Lacosamide Business (2017-2022)
7.4.5 MSN Laboratories Recent Development
7.5 Alembic Pharma
7.5.1 Alembic Pharma Company Details
7.5.2 Alembic Pharma Business Overview
7.5.3 Alembic Pharma Lacosamide Introduction
7.5.4 Alembic Pharma Revenue in Lacosamide Business (2017-2022)
7.5.5 Alembic Pharma Recent Development
7.6 Glenmark
7.6.1 Glenmark Company Details
7.6.2 Glenmark Business Overview
7.6.3 Glenmark Lacosamide Introduction
7.6.4 Glenmark Revenue in Lacosamide Business (2017-2022)
7.6.5 Glenmark Recent Development
7.7 Aurobindo Pharma
7.7.1 Aurobindo Pharma Company Details
7.7.2 Aurobindo Pharma Business Overview
7.7.3 Aurobindo Pharma Lacosamide Introduction
7.7.4 Aurobindo Pharma Revenue in Lacosamide Business (2017-2022)
7.7.5 Aurobindo Pharma Recent Development
7.8 Accord Healthcare
7.8.1 Accord Healthcare Company Details
7.8.2 Accord Healthcare Business Overview
7.8.3 Accord Healthcare Lacosamide Introduction
7.8.4 Accord Healthcare Revenue in Lacosamide Business (2017-2022)
7.8.5 Accord Healthcare Recent Development
7.9 Mylan
7.9.1 Mylan Company Details
7.9.2 Mylan Business Overview
7.9.3 Mylan Lacosamide Introduction
7.9.4 Mylan Revenue in Lacosamide Business (2017-2022)
7.9.5 Mylan Recent Development
7.10 Sun Pharma
7.10.1 Sun Pharma Company Details
7.10.2 Sun Pharma Business Overview
7.10.3 Sun Pharma Lacosamide Introduction
7.10.4 Sun Pharma Revenue in Lacosamide Business (2017-2022)
7.10.5 Sun Pharma Recent Development
7.11 Apotex
7.11.1 Apotex Company Details
7.11.2 Apotex Business Overview
7.11.3 Apotex Lacosamide Introduction
7.11.4 Apotex Revenue in Lacosamide Business (2017-2022)
7.11.5 Apotex Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Lacosamide Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Lacosamide Market Trends
Table 3. Lacosamide Market Drivers
Table 4. Lacosamide Market Challenges
Table 5. Lacosamide Market Restraints
Table 6. Global Lacosamide Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Lacosamide Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Lacosamide Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Lacosamide Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Lacosamide Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Lacosamide Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Lacosamide Revenue Share by Player, 2017-2022
Table 13. Global Lacosamide Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lacosamide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lacosamide as of 2021)
Table 15. Top Players of Lacosamide in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Lacosamide Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Lacosamide Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Lacosamide Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Lacosamide Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Lacosamide Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Lacosamide Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Lacosamide Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Lacosamide Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Lacosamide Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Lacosamide Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Lacosamide Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Lacosamide Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Lacosamide Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. UCB Company Details
Table 31. UCB Business Overview
Table 32. UCB Lacosamide Product
Table 33. UCB Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 34. UCB Recent Development
Table 35. Teva Company Details
Table 36. Teva Business Overview
Table 37. Teva Lacosamide Product
Table 38. Teva Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 39. Teva Recent Development
Table 40. Amneal Pharmaceuticals Company Details
Table 41. Amneal Pharmaceuticals Business Overview
Table 42. Amneal Pharmaceuticals Lacosamide Product
Table 43. Amneal Pharmaceuticals Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 44. Amneal Pharmaceuticals Recent Development
Table 45. MSN Laboratories Company Details
Table 46. MSN Laboratories Business Overview
Table 47. MSN Laboratories Lacosamide Product
Table 48. MSN Laboratories Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 49. MSN Laboratories Recent Development
Table 50. Alembic Pharma Company Details
Table 51. Alembic Pharma Business Overview
Table 52. Alembic Pharma Lacosamide Product
Table 53. Alembic Pharma Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 54. Alembic Pharma Recent Development
Table 55. Glenmark Company Details
Table 56. Glenmark Business Overview
Table 57. Glenmark Lacosamide Product
Table 58. Glenmark Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 59. Glenmark Recent Development
Table 60. Aurobindo Pharma Company Details
Table 61. Aurobindo Pharma Business Overview
Table 62. Aurobindo Pharma Lacosamide Product
Table 63. Aurobindo Pharma Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 64. Aurobindo Pharma Recent Development
Table 65. Accord Healthcare Company Details
Table 66. Accord Healthcare Business Overview
Table 67. Accord Healthcare Lacosamide Product
Table 68. Accord Healthcare Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 69. Accord Healthcare Recent Development
Table 70. Mylan Company Details
Table 71. Mylan Business Overview
Table 72. Mylan Lacosamide Product
Table 73. Mylan Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 74. Mylan Recent Development
Table 75. Sun Pharma Company Details
Table 76. Sun Pharma Business Overview
Table 77. Sun Pharma Lacosamide Product
Table 78. Sun Pharma Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 79. Sun Pharma Recent Development
Table 80. Apotex Company Details
Table 81. Apotex Business Overview
Table 82. Apotex Lacosamide Product
Table 83. Apotex Revenue in Lacosamide Business (2017-2022) & (US$ Million)
Table 84. Apotex Recent Development
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
List of Figures
Figure 1. Lacosamide Product Picture
Figure 2. Global Lacosamide Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Lacosamide Market Size 2017-2028 (US$ Million)
Figure 4. United States Lacosamide Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Lacosamide Market Size 2017-2028 (US$ Million)
Figure 6. United States Lacosamide Market Share in Global 2017-2028
Figure 7. Lacosamide Report Years Considered
Figure 8. Product Picture of Oral tablets
Figure 9. Product Picture of Oral solution
Figure 10. Product Picture of Intravenous
Figure 11. Global Lacosamide Market Share by Type in 2022 & 2028
Figure 12. Global Lacosamide Market Size by Type (2017-2028) & (US$ Million)
Figure 13. Global Lacosamide Market Share by Type (2017-2028)
Figure 14. United States Lacosamide Market Share by Type in 2022 & 2028
Figure 15. United States Lacosamide Market Size by Type (2017-2028) & (US$ Million)
Figure 16. United States Lacosamide Market Share by Type (2017-2028)
Figure 17. Product Picture of Adults
Figure 18. Product Picture of Pediatric patients
Figure 19. Global Lacosamide Market Share by Application in 2022 & 2028
Figure 20. Global Lacosamide Market Size by Application (2017-2028) & (US$ Million)
Figure 21. Global Lacosamide Market Share by Application (2017-2028)
Figure 22. United States Lacosamide Market Share by Application in 2022 & 2028
Figure 23. United States Lacosamide Market Size by Application (2017-2028) & (US$ Million)
Figure 24. United States Lacosamide Market Share by Application (2017-2028)
Figure 25. North America Lacosamide Market Size Growth Rate 2017-2028 (US$ Million)
Figure 26. U.S. Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 27. Canada Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Europe Lacosamide Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. Germany Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. France Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. U.K. Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Italy Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Russia Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Lacosamide Market Size Growth Rate 2017-2028 (US$ Million)
Figure 35. China Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Japan Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. South Korea Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. India Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Australia Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Taiwan Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Indonesia Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Thailand Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Malaysia Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Philippines Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Latin America Lacosamide Market Size Growth Rate 2017-2028 (US$ Million)
Figure 46. Mexico Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Brazil Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Argentina Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Lacosamide Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Turkey Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. U.A.E Lacosamide Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. UCB Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 54. Teva Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 55. Amneal Pharmaceuticals Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 56. MSN Laboratories Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 57. Alembic Pharma Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 58. Glenmark Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 59. Aurobindo Pharma Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 60. Accord Healthcare Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 61. Mylan Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 62. Sun Pharma Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 63. Apotex Revenue Growth Rate in Lacosamide Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
UCB Teva Amneal Pharmaceuticals MSN Laboratories Alembic Pharma Glenmark Aurobindo Pharma Accord Healthcare Mylan Sun Pharma Apotex